The GOALS framework streamlines sexual history taking to enhance the patient-clinician relationship and elicit information most useful for identifying an appropriate clinical course of action, such as screening, testing, and education.
Management of Syphilis, Gonorrhea, and Chlamydia in Patients With HIV
Please refer to CDC > Sexually Transmitted Infections Treatment Guidelines, 2021
- Purpose of This Guideline
- PrEP for Individuals at Risk of Acquiring HIV
- Choosing and Prescribing a PrEP Regimen
- Laboratory Testing Before PrEP Initiation
- Ongoing Laboratory Testing
- Managing a Positive HIV Test Result
- Discontinuing PrEP
- Appendix: Care Provider Checklists for PrEP Initiation, Regimen Choice, and Follow-Up
- All Recommendations
- Purpose of This Guideline
- Considerations and Contraindications
- COVID-19
- Haemophilus influenzae Type B (Hib)
- Hepatitis A Virus (HAV)
- Hepatitis B Virus (HBV)
- Human Papillomavirus (HPV)
- Influenza
- Measles, Mumps, Rubella (MMR)
- Meningococcal Serotypes A,C, W, and Y (MenACWY)
- Meningococcal Serotype B (MenB)
- Mpox
- Pneumococcal
- Tetanus, Diphtheria, and Pertussis (Tdap) and Tetanus-Diphtheria (Td)
- Varicella
- Zoster
- All Recommendations